Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $27,962 | $48,910 | $58,334 | $322,215 |
| - Cash | $15,098 | $12,138 | $34,905 | $39,898 |
| + Debt | $66,576 | $39,220 | $77,540 | $111,114 |
| Enterprise Value | $79,440 | $75,992 | $100,969 | $393,431 |
| Revenue | $11,698 | $12,059 | $12,752 | $11,782 |
| % Growth | -3% | -5.4% | 8.2% | – |
| Gross Profit | $2,704 | $2,550 | $3,303 | -$381 |
| % Margin | 23.1% | 21.1% | 25.9% | -3.2% |
| EBITDA | -$33,573 | -$49,771 | -$55,799 | -$59,594 |
| % Margin | -287% | -412.7% | -437.6% | -505.8% |
| Net Income | -$50,045 | -$61,618 | -$62,493 | -$77,702 |
| % Margin | -427.8% | -511% | -490.1% | -659.5% |
| EPS Diluted | -2.15 | -4.94 | -7.61 | -12.59 |
| % Growth | 56.5% | 35.1% | 39.6% | – |
| Operating Cash Flow | -$24,194 | -$40,196 | -$48,728 | -$47,323 |
| Capital Expenditures | -$509 | -$1,035 | -$554 | -$603 |
| Free Cash Flow | -$24,703 | -$41,231 | -$49,282 | -$47,926 |